| 1 | (Pyr1)apelin-13 | - | - | - | - | 1件: 86 86 💬 |
| 2 | 10 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP) | 1件: Dalfampridine Dalfampridine (4-AP) | 1件: Dalfampridine
Dalfampridine
💬 | 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬 |
| 3 | 100 mg AP1189 | - | - | - | - | 2件: 46 46, 222 💬 |
| 4 | 15 mg fampridine-SR (4-aminopyridine, 4-AP) | 1件: Dalfampridine Dalfampridine (4-AP) | 1件: Dalfampridine
Dalfampridine
💬 | 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬 |
| 5 | 1500mg mesalazine pellets
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 6 | 20 mg fampridine-SR (4-aminopyridine, 4-AP) | 1件: Dalfampridine Dalfampridine (4-AP) | 1件: Dalfampridine
Dalfampridine
💬 | 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬 |
| 7 | 20 mg sildenafil citrate by mouth
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 8 | 250mg mesalazine pellets
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 9 | 3K3A-APC Protein | - | - | - | - | 1件: 2 2 💬 |
| 10 | 4-AP | 1件: Dalfampridine Dalfampridine (4-AP) | 1件: Dalfampridine
Dalfampridine
💬 | 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬 |
| 11 | 5% sildenafil cream
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 50 50 💬 |
| 12 | 50 mg AP1189 | - | - | - | - | 1件: 46 46 💬 |
| 13 | 500mg mesalazine pellets
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 14 | 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 15 | 6aß - apomorphine-10,11-diol hydrochloride hemihydrate | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 16 | 750mg mesalazine pellets
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 17 | 90 mg hydrocortisone acetate suppository with Sephure suppository applicator | 3件: Acetate Acetate,
Hydrocortisone (Apres Peel Soothing Balm),
Hydrocortisone acetate | 2件: Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
| 18 | 90 mg idrocortisone acetato in supposta con appli | - | - | - | - | 1件: 97 97 💬 |
| 19 | 90 mg idrocortisone acetato in supposta con applicatore per supposte Sephure | - | - | - | - | 1件: 97 97 💬 |
| 20 | Access program - sildenafil citrate, Viagra, Revatio
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 21 | ADSVF application in the right hand | - | - | - | - | 1件: 51 51 💬 |
| 22 | Allo-APZ2-EB | - | - | - | - | 1件: 36 36 💬 |
| 23 | Allo-APZ2-OTS | - | - | - | - | 1件: 36 36 💬 |
| 24 | Any other approved Antiepileptic Drug | - | - | - | - | 1件: 144 144 💬 |
| 25 | AODG (Apigenin-7-O-glucuronide) | 1件: Apigenin Apigenin | - | - | - | 1件: 97 97 💬 |
| 26 | AP | - | - | - | - | 4件: 2 2, 6, 13, 299 💬 |
| 27 | AP-101 | - | - | - | - | 1件: 2 2 💬 |
| 28 | AP-CD/LD | - | - | - | - | 1件: 6 6 💬 |
| 29 | AP-PA02 | - | - | - | - | 1件: 299 299 💬 |
| 30 | AP01 | - | - | - | - | 1件: 85 85 💬 |
| 31 | AP09004 | - | - | - | - | 1件: 6 6 💬 |
| 32 | AP1189 | - | - | - | - | 2件: 46 46, 222 💬 |
| 33 | AP1189, 100 mg | - | - | - | - | 1件: 46 46 💬 |
| 34 | AP1189, 60 mg | - | - | - | - | 1件: 46 46 💬 |
| 35 | AP1189, 80 mg | - | - | - | - | 1件: 46 46 💬 |
| 36 | AP1903 | - | - | - | - | 3件: 60 60, 285, 326 💬 |
| 37 | AP1903 A594 | - | - | - | - | 3件: 60 60, 285, 326 💬 |
| 38 | Apabetalone | 1件: Apabetalone Apabetalone | 1件: Apabetalone
Apabetalone
💬 | 4件: BRD2 BRD2,
BRD3,
BRD4,
BRDT 💬 | - | 1件: 86 86 💬 |
| 39 | Apadamtase alfa | 1件: Apadamtase alfa Apadamtase alfa | - | - | - | 1件: 64 64 💬 |
| 40 | Apademtase alfa | - | - | - | - | 1件: 64 64 💬 |
| 41 | APCC, aPCC + TXA | - | - | - | - | 1件: 288 288 💬 |
| 42 | APD334 | - | - | - | - | 5件: 93 93, 96, 97, 98, 269 💬 |
| 43 | APD334 L-arginine | 2件: Arginine Arginine,
L-arginine | 1件: Arginine
Arginine
💬 | - | - | 1件: 97 97 💬 |
| 44 | APD371 | - | - | - | - | 1件: 96 96 💬 |
| 45 | APD421 | - | - | - | - | 1件: 107 107 💬 |
| 46 | APD811 | - | - | - | - | 1件: 86 86 💬 |
| 47 | Apelin | - | - | - | - | 1件: 86 86 💬 |
| 48 | API | - | - | - | - | 2件: 231 231, 299 💬 |
| 49 | API-AAT | - | - | - | - | 1件: 231 231 💬 |
| 50 | API-AAT, AD00370, ARC-AAT, API drug Substance | - | - | - | - | 1件: 231 231 💬 |
| 51 | Apigenin | 1件: Apigenin Apigenin | - | - | - | 2件: 6 6, 97 💬 |
| 52 | Apitegromab | 1件: Apitegromab Apitegromab | 1件: Apitegromab
Apitegromab
💬 | 1件: MSTN MSTN 💬 | 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 3 3 💬 |
| 53 | Apitox - pure honeybee toxin | - | - | - | - | 1件: 13 13 💬 |
| 54 | Apixaban | 1件: Apixaban Apixaban | 1件: Apixaban
Apixaban
💬 | 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 222 222 💬 |
| 55 | APL-130277 | - | - | - | - | 1件: 6 6 💬 |
| 56 | APL-1401 | - | - | - | - | 1件: 97 97 💬 |
| 57 | APL-2 | - | - | - | - | 5件: 2 2, 61, 62, 66, 222 💬 |
| 58 | APLA12 | - | - | - | - | 1件: 46 46 💬 |
| 59 | Aplindore | 1件: Aplindore Aplindore | - | - | - | 1件: 6 6 💬 |
| 60 | Aplindore MR tablets | 1件: Aplindore Aplindore | - | - | - | 1件: 6 6 💬 |
| 61 | APO-go | - | - | - | - | 1件: 6 6 💬 |
| 62 | APO-go® | - | - | - | - | 1件: 6 6 💬 |
| 63 | APO-P001 | - | - | - | - | 1件: 2 2 💬 |
| 64 | APOKINON | - | - | - | - | 1件: 6 6 💬 |
| 65 | APOKYN | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 66 | Apomor | - | - | - | - | 1件: 6 6 💬 |
| 67 | Apomorfina | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 68 | APOMORFINA CLORIDRATO | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 69 | Apomorp | - | - | - | - | 1件: 6 6 💬 |
| 70 | Apomorphine | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 5 5, 6, 7 💬 |
| 71 | Apomorphine 0.25% (2.5mg/ml) | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 72 | Apomorphine HCl injection | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 73 | APOMORPHINE HYDROCHLORIDE | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 74 | Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 75 | Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 76 | Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 77 | Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 78 | APOMORPHINE HYDROCHLORIDE HEMIHYDRATE | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 79 | Apomorphine Hydrocloride | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 80 | Apomorphine Hydrocloride Hemihydrate | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 81 | Apomorphine infusion | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 82 | Apomorphine Injectable Solution | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 83 | Apomorphine Nasal Powder | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 84 | APORON | - | - | - | - | 1件: 6 6 💬 |
| 85 | ApoTamox 10mg | - | - | - | - | 1件: 111 111 💬 |
| 86 | Application of Adalimumab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬 | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬 |
| 87 | Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side | 1件: Sinecatechins Sinecatechins | 1件: Sinecatechins
Sinecatechins
💬 | - | - | 1件: 160 160 💬 |
| 88 | Apraclonidine | 1件: Apraclonidine Apraclonidine | 1件: Apraclonidine
Apraclonidine
💬 | 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬 |
| 89 | Apraclonidine Hcl 0.5% Oph Soln | 1件: Apraclonidine Apraclonidine | 1件: Apraclonidine
Apraclonidine
💬 | 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬 |
| 90 | Apratastat | 1件: Apratastat Apratastat | 1件: Apratastat
Apratastat
💬 | 2件: ADAM17 ADAM17,
MMP13 💬 | 7件: Alzheimer disease Alzheimer disease, Coronavirus disease - COVID-19, Epithelial cell signaling in Helicobacter pylori infection, IL-17 signaling pathway, Notch signaling pathway, Parathyroid hormone synthesis, secretion and action, Relaxin signaling pathway 💬 | 1件: 46 46 💬 |
| 91 | Apremilast | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 7件: 46 46, 50, 56, 97, 107, 162, 271 💬 |
| 92 | Apremilast (CC-10004) | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 56 56 💬 |
| 93 | Apremilast 10 mg | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬 |
| 94 | Apremilast 20 mg | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 💬 |
| 95 | Apremilast 30 mg | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 💬 |
| 96 | Apremilast 30mg | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 50 50 💬 |
| 97 | Apremilast tablet 20 mg | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 💬 |
| 98 | Apremilast tablet 30 mg BID | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬 | 4件: PDE4A PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 💬 |
| 99 | APRINOX | - | - | - | - | 1件: 67 67 💬 |
| 100 | Apriso 0.375G ER CAP | - | - | - | - | 1件: 97 97 💬 |
| 101 | APRISO 375 mg extended-release capsules | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 97 97 💬 |
| 102 | AProArt | - | - | - | - | 1件: 65 65 💬 |
| 103 | Aprotinin | 1件: Aprotinin Aprotinin | 1件: Aprotinin
Aprotinin
💬 | - | - | 1件: 28 28 💬 |
| 104 | Aprovel | 1件: Irbesartan Irbesartan (Apo-irbesartan) | 1件: Irbesartan
Irbesartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬 |
| 105 | Aprovel (150 mg) | 1件: Irbesartan Irbesartan (Apo-irbesartan) | 1件: Irbesartan
Irbesartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
| 106 | Aprovel 150 mg Tablets | 1件: Irbesartan Irbesartan (Apo-irbesartan) | 1件: Irbesartan
Irbesartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
| 107 | APT-1011 | - | - | - | - | 1件: 98 98 💬 |
| 108 | APT-1011 - 3 mg | - | - | - | - | 1件: 98 98 💬 |
| 109 | APT-1011 3 mg HS | - | - | - | - | 1件: 98 98 💬 |
| 110 | APVO210 | - | - | - | - | 1件: 97 97 💬 |
| 111 | Autologous apoptotic cells injection | - | - | - | - | 1件: 46 46 💬 |
| 112 | Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII | - | - | - | - | 1件: 19 19 💬 |
| 113 | Azathioprine OR Mesalazine
(Apriso (TN)) | 2件: Azathioprine Azathioprine (Apo-azathioprine),
Mesalazine (Apriso) | 2件: Azathioprine
Azathioprine
,
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 96 96 💬 |
| 114 | Bosentan and Sildenafil
(Aphrodil (TN)) | 2件: Bosentan Bosentan (Apo-bosentan),
Sildenafil (Apo-sildenafil) | 3件: Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(Aphrodil (TN)) 💬 | 3件: EDNRA EDNRA,
EDNRB,
PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 115 | BPR277 ointment (controlled application) | - | - | - | - | 1件: 160 160 💬 |
| 116 | Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System | 1件: Brimonidine Brimonidine (Apo-brimonidine-timop) | 1件: Brimonidine
Brimonidine
💬 | 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 90 90 💬 |
| 117 | Cabotegravir
(APRETUDE) | 1件: Cabotegravir Cabotegravir (Apretude) | 1件: Cabotegravir
Cabotegravir
(APRETUDE) 💬 | - | - | 1件: 256 256 💬 |
| 118 | Cabotegravir (CAB) tablet
(APRETUDE) | 1件: Cabotegravir Cabotegravir (Apretude) | 1件: Cabotegravir
Cabotegravir
(APRETUDE) 💬 | - | - | 1件: 256 256 💬 |
| 119 | Cabotegravir - Injectable Suspension (CAB LA)
(APRETUDE) | 1件: Cabotegravir Cabotegravir (Apretude) | 1件: Cabotegravir
Cabotegravir
(APRETUDE) 💬 | - | - | 1件: 256 256 💬 |
| 120 | Canakinumab (WHO approval pending) | 1件: Canakinumab Canakinumab | 1件: Canakinumab
Canakinumab
💬 | 1件: IL1B IL1B 💬 | 44件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 1件: 106 106 💬 |
| 121 | Cannabidiol Oral Solution, is known as Epidyolex 100 mg/mL oral solution and is the approved name in the EU. Epidiolex (cannabidiol) oral solution is the approved name in the US. | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1,
CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 158 158 💬 |
| 122 | Captopril
(Apopril (TN)) | 1件: Captopril Captopril (Apo-capto Tab 50mg) | 1件: Captopril
Captopril
(Apopril (TN)) 💬 | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 2件: 17 17, 86 💬 |
| 123 | CBD - Oral Solution, is known as Epidiolex, and is the approved name in the USA. | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1,
CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 140 140, 144 💬 |
| 124 | CBD - Oral Solution, is known as Epidyolex, and is the approved name | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1,
CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬 |
| 125 | CBD - Solution Orale, conosciuto come Epidiolex, questo è il nome approvato negli Stati Uniti | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1,
CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬 |
| 126 | CBD Oral solution, is known as Epidyolex and is the approved name in the EU | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1,
CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬 |
| 127 | CBD soluzione orale nota come Epidyolex e con tale nome è stato approvato in UE | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1,
CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬 |
| 128 | CBD-Oral Solution, is known as Epidiolex, and is the approved name in the USA. | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1,
CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 158 158 💬 |
| 129 | Continuous Apomorphine infusion | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 130 | Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine)
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 2件: 96 96, 97 💬 |
| 131 | Corticosteroids (Aprednislon) | - | - | - | - | 1件: 63 63 💬 |
| 132 | CR002 Liquid API | 1件: CR002 CR002 | - | - | - | 1件: 299 299 💬 |
| 133 | Crocin and Apigenin | 2件: Apigenin Apigenin,
Crocin | - | - | - | 1件: 6 6 💬 |
| 134 | D.3.2 Product code where applicable13: | - | - | - | - | 1件: 193 193 💬 |
| 135 | Delayed and extended release mesalazine
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 136 | Dopaminergic Agonist + Apomorphine | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 137 | Duo-Therapy with Sildenafil + Bosentan
(Aphrodil (TN)) | 2件: Bosentan Bosentan (Apo-bosentan),
Sildenafil (Apo-sildenafil) | 3件: Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(Aphrodil (TN)) 💬 | 3件: EDNRA EDNRA,
EDNRB,
PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 138 | EB-101 Surgical application of RDEB wounds | - | - | - | - | 1件: 36 36 💬 |
| 139 | Epidyolex and is the approved name in the EU | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬 | 2件: CNR1 CNR1,
CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬 |
| 140 | ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)
(Aphrodil (TN)) | 4件: Bosentan Bosentan (Apo-bosentan),
Macitentan,
Sildenafil (Apo-sildenafil),
Tadalafil (Apo-tadalafil Pah) | 5件: Bosentan
Bosentan
,
Tadalafil
,
Bosentan
,
Sildenafil
(Aphrodil (TN)),
Macitentan
💬 | 3件: EDNRA EDNRA,
EDNRB,
PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 141 | EU-approved RoActemra | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬 | 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬 |
| 142 | EUR-1008 (APT-1008) | - | - | - | - | 1件: 299 299 💬 |
| 143 | EUR-1008 (APT-1008) High Dose | - | - | - | - | 1件: 298 298 💬 |
| 144 | EUR-1008 (APT-1008) Low Dose | - | - | - | - | 1件: 298 298 💬 |
| 145 | Ex-vivo approach concerning 25 patients | - | - | - | - | 2件: 102 102, 299 💬 |
| 146 | Firategrast (USAN approved name) | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬 | 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬 |
| 147 | G04BE03- Sildenafil - sildenafil (citrato)
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 148 | Group 3: ustekinumab approximately 6 mg/kg | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬 | 3件: IL12A IL12A,
IL12B,
IL23A 💬 | 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬 |
| 149 | Hydrokortison APL kapsel 2,5 mg | - | - | - | - | 1件: 83 83 💬 |
| 150 | In-vitro approach concerning 25 patients | - | - | - | - | 2件: 102 102, 299 💬 |
| 151 | Injection of apomorphine | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 152 | Interferon beta-1a (current approved manufacturing process invloving FBS) | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬 | 2件: IFNAR1 IFNAR1,
IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬 |
| 153 | Investigators Choice of Approved AED | - | - | - | - | 1件: 144 144 💬 |
| 154 | Investigators choice of approved AEDs | - | - | - | - | 1件: 144 144 💬 |
| 155 | Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-03 | 1件: Irbesartan Irbesartan (Apo-irbesartan) | 1件: Irbesartan
Irbesartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 66 66, 222 💬 |
| 156 | Irbesartan tablets (NDC# 31722-729-30 approved in the United states) | 1件: Irbesartan Irbesartan (Apo-irbesartan) | 1件: Irbesartan
Irbesartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
| 157 | Irbesartan tablets (NDC# 43547-0374-03 and NDC 43547-374-09, approved in the USA) Generic tablets distributed by Solco Healthcare US, LLC | 1件: Irbesartan Irbesartan (Apo-irbesartan) | 1件: Irbesartan
Irbesartan
💬 | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬 |
| 158 | IV Apomorphine | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 159 | Kamada-API | - | - | - | - | 1件: 231 231 💬 |
| 160 | Lithium Apogepha | 2件: Lithium carbonate Lithium carbonate (Apo-lithium Carbonate),
Lithium citrate | 2件: Lithium carbonate
Lithium carbonate
,
Lithium citrate
💬 | - | - | 1件: 2 2 💬 |
| 161 | Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI) | - | - | - | - | 1件: 13 13 💬 |
| 162 | Mesalazine
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 3件: 46 46, 96, 97 💬 |
| 163 | Mesalazine (3,600 mg)
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 164 | Mesalazine (Asacol®)
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 165 | Mesalazine (Mesalamine)
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 96 96 💬 |
| 166 | Mesalazine - TID 1000 mg
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 167 | Mesalazine - TID 2x 500 mg
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 168 | Mesalazine 1000 mg gastro-resistant tablets
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 169 | Mesalazine 250Mg
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 170 | Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet
(Apriso (TN)) | 2件: Mesalazine Mesalazine (Apriso),
Nitazoxanide | 2件: Mesalamine
Mesalamine
(Apriso (TN)),
Nitazoxanide
💬 | - | - | 1件: 97 97 💬 |
| 171 | Mesalazine 4G Enema
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 172 | Mesalazine 500 mg gastro-resistant tablets (Salofa
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 173 | Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 174 | Mesalazine EC 500 mg
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 96 96 💬 |
| 175 | Mesalazine Enema
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 176 | Mesalazine liquid enema
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 177 | Mesalazine slow-release granules
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 178 | Mesalazine Sustained-Release Tablets
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 96 96 💬 |
| 179 | Mesalazine tablet
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 180 | Mesalazine tablets
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 96 96 💬 |
| 181 | Mesalazine with hydrocortisone sodium succinate
(Apriso (TN)) | 2件: Hydrocortisone Hydrocortisone (Apres Peel Soothing Balm),
Mesalazine (Apriso) | 2件: Hydrocortisone
Hydrocortisone
,
Mesalamine
(Apriso (TN)) 💬 | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 💬 |
| 182 | Mesalazine, Tripterygium glycosides
(Apriso (TN)) | 2件: Mesalazine Mesalazine (Apriso),
Tripterygium wilfordii whole | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 96 96 💬 |
| 183 | MMX mesalamine/ mesalazine
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 184 | MMX Mesalamine/Mesalazine
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 185 | MMX Mesalamine/Mesalazine (High Dose)
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 186 | MMX Mesalamine/Mesalazine (Low Dose)
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 187 | Mono-Therapy with Sildenafil
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 188 | Non applicabile | - | - | - | - | 4件: 13 13, 49, 51, 256 💬 |
| 189 | Non applicable | - | - | - | - | 2件: 10 10, 19 💬 |
| 190 | Oral sildenafil
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 191 | Overencapsulated mesalazine tablets
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 192 | Part 1 Levulan surface application | - | - | - | - | 1件: 34 34 💬 |
| 193 | Part 1 Levulan surface application twice | - | - | - | - | 1件: 34 34 💬 |
| 194 | Part 1 Levulan surface application twice with microneedling | - | - | - | - | 1件: 34 34 💬 |
| 195 | Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses | - | - | - | - | 1件: 46 46 💬 |
| 196 | Pegcetacoplan (APL-2) | 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan
Pegcetacoplan
💬 | 1件: C3 C3 💬 | 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 3件: 2 2, 61, 62 💬 |
| 197 | Pharmacologic approaches to glycemic treatment | - | - | - | - | 1件: 298 298 💬 |
| 198 | Primary Cervical Dystonia (Trihexyphenidyl)
(Apo-trihex (TN)) | 1件: Trihexyphenidyl Trihexyphenidyl (Aparkane Tab 5mg) | 1件: Trihexyphenidyl
Trihexyphenidyl
(Apo-trihex (TN)) 💬 | 5件: CHRM1 CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 199 | Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN01 | 2件: Alunacedase alfa Alunacedase alfa,
Angiotensin II | 2件: Angiotensin II
Angiotensin II
,
Angiotensin II
💬 | 2件: AGTR1 AGTR1,
AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 200 | Recombinant Human Apolipoprotein | - | - | - | - | 1件: 79 79 💬 |
| 201 | Recombinant Human Apolipoprotein A-I | - | - | - | - | 1件: 79 79 💬 |
| 202 | Recombinant Human Apolipoprotein A-I/Phospholipids Complex | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 1件: 79 79 💬 |
| 203 | Recombinant human apolipoprotein a1 | - | - | - | - | 1件: 79 79 💬 |
| 204 | Riociguat granules 0.3% for oral application | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬 | 3件: GUCY1A1 GUCY1A1,
GUCY1A2,
GUCY1B1 💬 | 11件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 205 | S.c. apomorphine | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 206 | Sildenafil
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
| 207 | Sildenafil (50 mg)
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬 |
| 208 | Sildenafil (Acute-1 hour)
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬 |
| 209 | Sildenafil (as citrate)
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 210 | Sildenafil (REVATIO)
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 211 | Sildenafil (Revatio) 20 mg TID
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 212 | Sildenafil (Subchronic-4 weeks)
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬 |
| 213 | Sildenafil 20 mg tablets
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 278 278 💬 |
| 214 | Sildenafil 20mg
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
| 215 | Sildenafil 20mg and Bosentan 62.5mg
(Aphrodil (TN)) | 2件: Bosentan Bosentan (Apo-bosentan),
Sildenafil (Apo-sildenafil) | 3件: Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(Aphrodil (TN)) 💬 | 3件: EDNRA EDNRA,
EDNRB,
PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬 |
| 216 | Sildenafil 40mg oral capsule
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬 |
| 217 | Sildenafil and Losartan
(Aphrodil (TN)) | 2件: Losartan Losartan (Apo-losartan/hctz),
Sildenafil (Apo-sildenafil) | 2件: Losartan
Losartan
,
Sildenafil
(Aphrodil (TN)) 💬 | 2件: AGTR1 AGTR1,
PDE5A 💬 | 18件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬 |
| 218 | Sildenafil by injection
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 210 210 💬 |
| 219 | SILDENAFIL CITRATE
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 4件: 51 51, 85, 86, 225 💬 |
| 220 | Sildenafil citrate (UK-92,480)
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 221 | Sildenafil Filmtabletten
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 222 | Sildenafil Oral Suspension
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 294 294 💬 |
| 223 | Sildenafil singly or in association with Bosentan
(Aphrodil (TN)) | 2件: Bosentan Bosentan (Apo-bosentan),
Sildenafil (Apo-sildenafil) | 3件: Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(Aphrodil (TN)) 💬 | 3件: EDNRA EDNRA,
EDNRB,
PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 224 | Sildenafil therapy
(Aphrodil (TN)) | 1件: Sildenafil Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬 |
| 225 | Sitaxsentan and Sildenafil
(Aphrodil (TN)) | 2件: Sildenafil Sildenafil (Apo-sildenafil),
Sitaxentan | 2件: Sitaxentan
Sitaxentan
,
Sildenafil
(Aphrodil (TN)) 💬 | 2件: EDNRA EDNRA,
PDE5A 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 226 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth
(Aphrodil (TN)) | 2件: Dextrose, unspecified form Dextrose, unspecified form,
Sildenafil (Apo-sildenafil) | 1件: Sildenafil
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 227 | SPD476 (mesalazine)
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 228 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine
(Apriso (TN)) | 1件: Mesalazine Mesalazine (Apriso) | 1件: Mesalamine
Mesalamine
(Apriso (TN)) 💬 | - | - | 1件: 97 97 💬 |
| 229 | Spironolactone captopril carvedilol
(Apopril (TN)) | 3件: Captopril Captopril (Apo-capto Tab 50mg),
Carvedilol (Apo-carvedilol),
Spironolactone (Apo-spirozide Tab) | 3件: Captopril
Captopril
(Apopril (TN)),
Carvedilol
,
Spironolactone
💬 | 7件: ACE ACE,
ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2,
NR3C2 💬 | 19件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬 |
| 230 | Subcutaneous apomorphine | 1件: Apomorphine Apomorphine | 1件: Apomorphine
Apomorphine
💬 | 2件: DRD1 DRD1,
DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬 |
| 231 | Tadalafil and Sildenafil
(Aphrodil (TN)) | 2件: Sildenafil Sildenafil (Apo-sildenafil),
Tadalafil (Apo-tadalafil Pah) | 2件: Tadalafil
Tadalafil
,
Sildenafil
(Aphrodil (TN)) 💬 | 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬 |
| 232 | Tezepelumab via APFS | 1件: Tezepelumab Tezepelumab | 1件: Tezepelumab
Tezepelumab
💬 | 1件: TSLP TSLP 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 98 98 💬 |
| 233 | Tipranavir
(Aptivus (TN)) | 1件: Tipranavir Tipranavir (Aptivus) | 1件: Tipranavir
Tipranavir
(Aptivus (TN)) 💬 | - | - | 1件: 265 265 💬 |
| 234 | Trifluoperazine
(Apo-trifluoperazine (TN)) | 1件: Trifluoperazine Trifluoperazine | 2件: Trifluoperazine maleate
Trifluoperazine maleate
,
Trifluoperazine
(Apo-trifluoperazine (TN)) 💬 | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 283 283, 284 💬 |
| 235 | Trihexyphenidyl
(Apo-trihex (TN)) | 1件: Trihexyphenidyl Trihexyphenidyl (Aparkane Tab 5mg) | 1件: Trihexyphenidyl
Trihexyphenidyl
(Apo-trihex (TN)) 💬 | 5件: CHRM1 CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 5 5, 6 💬 |
| 236 | Ustekinumab (approximately 6 mg/kg) | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬 | 3件: IL12A IL12A,
IL12B,
IL23A 💬 | 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 49 49 💬 |
| 237 | Ustekinumab approximately 6 mg/kg (IV) | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬 | 3件: IL12A IL12A,
IL12B,
IL23A 💬 | 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬 |
| 238 | VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide | 1件: Volanesorsen Volanesorsen | 1件: Volanesorsen
Volanesorsen
💬 | 1件: APOC3 APOC3 💬 | 2件: Cholesterol metabolism Cholesterol metabolism, PPAR signaling pathway 💬 | 1件: 265 265 💬 |